Table 2.
Univariate Analysis of Clinical Data, Blood Indicators, and Osteoporosis of Different Gender Groups
| Female | Male | |
|---|---|---|
| OR (95% CI) P-value | OR (95% CI) P-value | |
| Age | 1.05 (1.00, 1.12) 0.066 | 1.01 (0.97, 1.06) 0.644 |
| Menopause | 1.15 (0.23, 5.74) 0.867 | —— |
| BMI (kg/m2) | 0.99 (0.87, 1.12) 0.835 | 1.03 (0.90, 1.18) 0.686 |
| Waist-to-hip ratio | 1.72 (0.00, 32,015.04) 0.914 | 0.68 (0.00, 1914.25) 0.924 |
| Disease course (years) | 1.03 (0.97, 1.10) 0.293 | 1.06 (0.98, 1.14) 0.138 |
| Drug control | 0.90 (0.29, 2.78) 0.855 | 1.80 (0.68, 4.79) 0.241 |
| Fasting blood glucose (mmol/L) | 1.12 (0.89, 1.41) 0.329 | 0.84 (0.66, 1.06) 0.141 |
| Fasting C peptide (pmol/L) | 1.36 (0.79, 2.34) 0.262 | 0.89 (0.56, 1.41) 0.613 |
| HOMA-IR (CP) | 1.55 (0.99, 2.42) 0.055 | 0.80 (0.51, 1.26) 0.333 |
| HOMA-islet (CP-DM) | 0.99 (0.97, 1.02) 0.627 | 1.00 (0.99, 1.01) 0.531 |
| HbA1c (%) | 1.18 (0.91, 1.52) 0.214 | 0.86 (0.68, 1.10) 0.244 |
| Uric acid (μmol/L) | 0.99 (0.99, 1.00) 0.074 | 1.00 (1.00, 1.01) 0.323 |
| Total cholesterol (mmol/L) | 1.02 (0.60, 1.74) 0.941 | 0.78 (0.49, 1.24) 0.291 |
| Triacylglycerol (mmol/L) | 0.82 (0.52, 1.28) 0.385 | 0.94 (0.75, 1.17) 0.575 |
| High-density lipoprotein (mmol/L) | 2.46 (0.26, 23.58) 0.434 | 1.09 (0.16, 7.31) 0.933 |
| Low-density lipoprotein (mmol/L) | 1.08 (0.53, 2.21) 0.830 | 0.68 (0.34, 1.35) 0.265 |
Abbreviations: BMI, body mass index; HOMA-IR (CP), homeostasis model assessment for insulin resistance based on C-peptide; HOMA-islet (CP-DM), homeostasis model assessment islet beta-cell function based on C-peptide; HbA1c, hemoglobin A1c.